Summary & Overview
CPT 28124: Toe Phalanx Excision with Craterization or Diaphysectomy
CPT code 28124 denotes surgical removal of infected portions of a toe phalanx using craterization, saucerization, or diaphysectomy. Nationally, this code represents a targeted orthopedic/podiatric procedure used to manage focal osseous infection of the toe and can affect coding, coverage determination, and episode cost for lower-extremity surgical care. Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
This publication provides a concise reference for clinicians, coders, and policy analysts. Readers will find: a clinical context for when the procedure is billed, typical sites of service, common payer coverage considerations, and benchmark-oriented content relevant to utilization and coding practice. The content summarizes how CPT code 28124 fits into surgical management of toe phalanx infections and what stakeholders should expect when encountering this code in claims and billing workflows. Data not available in the input.
Billing Code Overview
CPT code 28124 describes a surgical procedure in which the provider removes the infected portion of a toe phalanx using craterization, saucerization, or diaphysectomy. This procedure is aimed at excising diseased bone tissue from a toe phalanx to control infection and preserve surrounding structures.
-
Service type: Surgical bone debridement of a toe phalanx
-
Typical site of service: Ambulatory surgical center or hospital outpatient department; may also be performed in an operating room for inpatient cases
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting with a chronic or acute toe infection involving the distal or proximal phalanx (osteomyelitis, infected nonhealing ulcer with exposed bone, or severe paronychia with bony involvement) that has failed conservative therapy (oral/IV antibiotics, wound care, partial nail removal). The patient often has comorbidities such as diabetes mellitus, peripheral vascular disease, or neuropathy that predispose to progressive soft-tissue and bony infection. Evaluation includes history, physical exam of the foot and toe, wound culture, laboratory studies (CBC, inflammatory markers), and imaging (plain radiographs; MRI if needed) confirming cortical destruction or sequestrum of the phalanx.
The clinical workflow: pre-procedure consent and medical clearance; perioperative antibiotics as indicated; local block or regional/general anesthesia; debridement of infected bone using craterization, saucerization, or diaphysectomy to remove sequestra and infected phalanx segments; copious irrigation; hemostasis and wound closure or partial closure with sterile dressing; postoperative instructions and follow-up for wound checks, continued antibiotics guided by culture, and consideration of further reconstruction if needed. Typical site of service is an outpatient ambulatory surgery center or hospital operating room depending on anesthesia and comorbidity. Service type: minor surgical procedure (osseous debridement/partial phalangeal resection) of the toe phalanx.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 |